🔎 Trials Near Me

Home › Myelodysplastic Syndromes › Alabama › Birmingham

Myelodysplastic Syndromes clinical trials in Birmingham, AL

10 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • University of Alabama at Birmingham Cancer Center, Birmingham
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Recruiting
  • University of Alabama at Birmingham, Birmingham
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

RecruitingPhase 1
  • University of Alabama at Birmingham, Birmingham
4 Weeks – 75 Years · All sexes · Updated Apr 13, 2026 · NCT06047886

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

RecruitingPhase 1
  • University of Alabama at Birmingham, Birmingham
Ages 18 to 75 · All sexes · Updated Mar 4, 2026 · NCT07044544

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

RecruitingPhase 1
  • University of Alabama O'Neal Cancer Center, Birmingham
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT05143996

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Birmingham
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

RecruitingPhase 2
  • University of Alabama at Birmingham, Birmingham
Ages 18 to 75 · All sexes · Updated Oct 8, 2025 · NCT06265584

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

RecruitingPhase 2
  • University of Alabama at Birmingham, Birmingham
Ages 18 to 60 · All sexes · Updated Oct 8, 2025 · NCT06315309

HPC Offered for PRESERVE Expansion

RecruitingObservational study
  • University of Alabama, Birmingham, Birmingham
Ages 12 to 80 · All sexes · Updated Aug 28, 2025 · NCT07145411

About Myelodysplastic Syndromes

Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.

More about Myelodysplastic Syndromes on MedlinePlus

Myelodysplastic Syndromes trials in other cities

Other studies in Birmingham

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.